Finance · Search · Sign in · Sign up

Pasty sells MDVN 72.8: Short-term Underperformance Detected in Shares of Osiris Therapeutics in the Biotechnology Industry (OSIR, KERX, PCYC, MDVN, VND ...


Medivation (NASDAQ:MDVN) follows with a loss of 1.06% and Vanda Pharmaceuticals (NASDAQ:VNDA) rounds out the bottom five with a loss of 1.04%. Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective . ... ...


42 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home